Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Updated Food Recall Warning - Certain K&K Foodliner brand pork schnitzel products recalled due to E. coli O157:H7


Product photos are available at http://www.inspection.gc.ca/eng/1525303780700/1525303785365

OTTAWA, May 2, 2018 /CNW/ - The food recall warning issued on April 25, 2018 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

K&K Foodliner is recalling certain pork schnitzel products from the marketplace due to possible E. coli O157:H7 contamination. Consumers should not consume the recalled products described below.

The following products have been sold in Alberta.

Recalled products

 

Brand

Product

Size

UPC

Codes

K&K Foodliner

Pork Schnitzel

Variable

Starts with 0 202546

All products with "packed on" dates from 2018.FE.21 to 2018.AL.13, inclusively

K&K Foodliner

Pork Schnitzel ? Breaded Italian Style

Variable

Starts with 0 202548

All products with "packed on" dates from 2018.FE.21 to 2018.AL.13, inclusively

K&K Foodliner

Pork Schnitzel ? Breaded

Variable

Starts with 0 202547

All products with "packed on" dates from 2018.FE.21 to 2018.AL.13, inclusively

K&K Foodliner

Pork Schnitzel ? Breaded Buffalo Style

Variable

Starts with 0 202570

All products with "packed on" dates from 2018.FE.21 to 2018.AL.13, inclusively

 

What you should do

If you think you became sick from consuming a recalled product, call your doctor.

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

Food contaminated with E. coli O157:H7 may not look or smell spoiled but can still make you sick. Symptoms can include nausea, vomiting, mild to severe abdominal cramps and watery to bloody diarrhea. In severe cases of illness, some people may have seizures or strokes, need blood transfusions and kidney dialysis or live with permanent kidney damage. In severe cases of illness, people may die.

Background

This recall was triggered by the E. coli O157:H7 foodborne outbreak investigation led by Alberta Health Services (AHS) and supported by the CFIA.   The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Illnesses

Alberta Health Services are investigating an outbreak of human illness. Please refer to the AHS Edmonton E. coli Outbreak Health Advisory for further details on this active outbreak investigation.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 11:40
The "Musculoskeletal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Musculoskeletal Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the...

at 11:30
The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of option and evaluation deals from 2016 to 2024....



News published on and distributed by: